For additional details see Appendix S2
10.1016/j.ejphar.2012.11.055 20 ChangC
The body text adds that tirzepatide shows numerically higher weight-loss outcomes in clinical trials while semaglutide offers a longer safety record and more established protocols
This suggests that low-dose prebiotics can boost gut health without disrupting the balance of the microbiome
Say goodbye to starvation diets, weight loss drugs, and low-calorie diet products
Overall 32.2% of subjects had LH at only one site, and 65.8% of patients had LH at several site levels, primarily the abdomen (52.4%), followed by thighs (23.2%), arms (19.9%), and other unusual areas (4.5%), including the thigh area located immediately distal to the crural region, the areas immediately above the knee, and the proximal arm region (34.2%)